Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia
Clinical trial NCT06667973 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06667973
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2028-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.